BETRFOTCPharmaceutical PreparationsFiscal year ends January 31
BetterLife Pharma Inc.
Financials through fiscal 2026, year ended Jan 31, 2026Last filing: 20-F on Jun 1, 2026
$0.15−0.01 (-3.71%)
Close on Oct 19, 2026
- Market cap
- $22.36M
- P/E (TTM)
- –
- Dividend yield
- –
BetterLife Pharma statistics
Financials through Jan 31, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | BetterLife Pharma | Industry median |
|---|---|---|
| Market Cap | $5.81M | $166.30M |
| Enterprise Value | $5.81M | $88.19M |
Efficiency
| Measure | BetterLife Pharma | Industry median |
|---|---|---|
| Employee Count | 56 | 74 |
Shares
| Measure | BetterLife Pharma | Industry median |
|---|---|---|
| Shares Outstanding | 37,929,800 | 58,127,000 |
| Shares Change (YoY) | 17.8% | 10.9% |
| Float | 37,929,800 | 49,136,700 |
| Shares Held by Insiders | 0.00% | 11.6% |
Calculated by StockData from BetterLife Pharma's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.